Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Payet

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Joint Bone Spine|June 15, 2010
TNFα antagonist therapy does not increase the Epstein-Barr virus burden in patients with rheumatoid arthritis or ankylosing spondylitisMarion Couderc, Sarah Payet, Cécile Henquell, et al.
Joint Bone Spine|June 18, 2010
Elderly-onset rheumatoid arthritisMartin Soubrier, Sylvain Mathieu, Sarah Payet, et al.
Arthritis Care & Research|October 10, 2014
Efficacy and safety of rituximab in elderly patients with rheumatoid arthritis enrolled in a French Society of Rheumatology registrySarah Payet, Martin Soubrier, Elodie Perrodeau, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Joint Bone Spine|June 15, 2010
TNFα antagonist therapy does not increase the Epstein-Barr virus burden in patients with rheumatoid arthritis or ankylosing spondylitisMarion Couderc, Sarah Payet, Cécile Henquell, et al.
Joint Bone Spine|June 18, 2010
Elderly-onset rheumatoid arthritisMartin Soubrier, Sylvain Mathieu, Sarah Payet, et al.
Arthritis Care & Research|October 10, 2014
Efficacy and safety of rituximab in elderly patients with rheumatoid arthritis enrolled in a French Society of Rheumatology registrySarah Payet, Martin Soubrier, Elodie Perrodeau, et al.
Pageof 1